MC
Marc Cobo sold $185 of BBOT stock
Marc Cobo, Principal Accounting Officer of BridgeBio Oncology Therapeutics, Inc. (BBOT), sold 78 shares of BBOT stock worth $185, per an SEC Form 4 filed Nov 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 13, 2026, 4 days before it was made public.
BBOT has moved -15.7% since the trade date, from $2.14 to $1.80 (Nov 18, 2026 close).
- Traded
- Nov 13, 2026
- Disclosed
- Nov 17, 2026
- Filing delay
- 4 days
- Price since
- -15.7%
- Role
- Principal Accounting Officer
- Source
- SEC Form 4